Rain Therapeutics Inc. (RAIN) Tops Q4 EPS by 126c

Rain Therapeutics Inc. (NASDAQ: RAIN) reported Q4 EPS of $0.70, $1.26 better than the analyst estimate of ($0.56).

For earnings history and earnings-related data on Rain Therapeutics Inc. (RAIN) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform
• JPMorgan Upgrades Cholamandalam Investment and Finance (CIFC:IN) to Overweight